Fred Martin
Disciplined Growth Investors
Fred Martin Amgen Inc stake
total: 241
Disciplined Growth Investors AMGN trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2014 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2014 Q3
According to 2026 Q2 report, Fred Martin doesn't hold any Amgen Inc (AMGN) shares. To date, the estimated cost basis is nearly $118.42 for "buy" trades and estimated average "sell" price is $118.42. Disciplined Growth Investors first purchased AMGN in 2014 Q2, initially acquiring 4,045 shares. Since the initial investment in Amgen Inc (AMGN), Disciplined Growth Investors has made 1 more transaction.
When did Fred Martin sell Amgen Inc (AMGN)?
Fred Martin sold off the entire Amgen Inc (AMGN) position in 2014 Q3.
When did Fred Martin buy Amgen Inc (AMGN)?
Fred Martin first invested in Amgen Inc (AMGN) in 2014 Q2 at the reported quarter-end price of $118.42 per share.
What's the cost basis of Disciplined Growth Investors's AMGN stake?
The estimated cost basis for Amgen Inc (AMGN) stake is around $118.42 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $118.42
- Weighted AVG sell price:
- $118.42
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.